Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Differentiation

Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells

Abstract

We originally reported that vitamin K2 (VK2) analogs, including menaquinone 4 (MK4) but not vitamin K1, effectively induce apoptosis in various types of primary cultured leukemia cells and leukemia cell lines in vitro. It has also been reported by others that VK2 showed the differentiation-inducing activity in leukemia cell lines. To investigate the discrepancy between apoptosis- and differentiation-inductions of leukemia cells by VK2 treatment, we used bcl-2 gene transfected HL-60 cells (HL-60-bcl-2) which resulted in five-fold over-expression of BCL-2 protein, and then compared the effects of MK4 to the control HL-60-neo cells. Seventy-two hours of exposure to various concentrations of MK4 resulted in growth inhibition of these cells in a dose-dependent manner (0.1–50 μM), however, HL-60-bcl-2 was less sensitive against MK4. MK4 potently induced apoptosis of HL-60-neo cells along with the depolarization of mitochondrial membrane potential and caspase-3 activation. Notably, HL-60-bcl-2 was almost completely resistant to apoptosis induction in response to MK4, although cell growth inhibition was still observed. In spite of the abrogation of apoptosis induction, about 90% of HL-60-bcl-2 cells were arrested in the G0/G1 phase within 48 h of exposure to 10 μM of MK4 accompanied by up-modulation of p27KIP1 expression. Concomitantly, HL-60-bcl-2 cells underwent monocytic differentiation. These data suggest that VK2 also shows the differentiation inducing effects on leukemia cells which are resistant against VK2-inducing apoptosis. The dichotomous nature of VK2 against leukemia cells appears to have clinical benefits for the treatment of patients with leukemias and myelodysplastic syndromes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Dorr RT . Cytoprotective agents for anthracyclines Semin Oncol 1996 23: 23–34

    CAS  PubMed  Google Scholar 

  2. Shearer MJ . Vitamin K metabolism and nutriture Blood Rev 1992 6: 92–104

    Article  CAS  PubMed  Google Scholar 

  3. Yaguchi M, Miyazawa K, Katagiri T, Nishimaki J, Kizaki M, Tohyama K, Toyama K . Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance of all-trans retinoic acid Leukemia 1997 11: 779–787

    Article  CAS  PubMed  Google Scholar 

  4. Wang Z, Wang M, Finn F, Carr BI . The growth inhibitory effect of vitamins K and their actions on gene expression Hepatology 1995 22: 875–882

    Google Scholar 

  5. Juan C-C, Wu FY-H . Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase Biochem Biophys Res Commun 1993 190: 907–913

    Article  CAS  PubMed  Google Scholar 

  6. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, Zheng ZB, Kerns J, Naganathan SJ . Growth inhibition of hepatoma cells induced by vitamin K and its analogs J Biol Chem 1995 270: 28304–28310

    Article  CAS  PubMed  Google Scholar 

  7. Wu FY-H, Cahng NT, Cehn WJ, Juan CC . Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc Oncogene 1993 8: 2237–2244

    CAS  PubMed  Google Scholar 

  8. Nutter LM, Ngo EO, Fisher GR, Gutierrez PL . DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxioreductase J Biol Chem 1992 267: 2474–2479

    CAS  PubMed  Google Scholar 

  9. Talcott RE, Ketterman A, Giannini DG . Inactivation of microsomal NADPH-cytochrome c reductase by sulfhydryl-reactive derivatives of menadione Biochem Pharmacol 1994 33: 2663–2668

    Article  Google Scholar 

  10. Ohizumi H, Masuda Y, Nakajo S, Sakai I, Ohsawa S, Nakaya K . Geranylgeraniol is a potent inducer of apoptosis in tumor cells J Biochem 1995 117: 11–13

    Article  CAS  PubMed  Google Scholar 

  11. Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K, Takiguchi T . Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome Leukemia 1999 13: 1399–1405

    Article  CAS  PubMed  Google Scholar 

  12. Sakai I, Hashimoto S, Yoda M, Hida T, Ohsawa S, Nakajo S, Nakayama K . Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines Biochem Biophys Res Commun 1994 205: 1305–1310

    Article  CAS  PubMed  Google Scholar 

  13. Yaguchi M, Miyazawa K, Otawa M, Ito Y, Kawanishi Y, Toyama K . Vitamin K2 therapy for a patient with myelodysplastic syndrome Leukemia 1999 13: 144–145

    Article  CAS  PubMed  Google Scholar 

  14. Miyazawa K, Nishimaki J, Ohyashiki K, Enomoto S, Kuriya S, Fukuda R, Hotta T, Teramura M, Mizoguchi H, Uchiyama T, Omine M . Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: Information through a questionnaire survey of multi-center pilot studies in Japan Leukemia 2000 14: 1156–1157

    Article  CAS  PubMed  Google Scholar 

  15. Takami A, Nakao S, Ontachi Y, Yamauchi H, Matsuda T . Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog Int J Hematol 1999 69: 24–26

    CAS  PubMed  Google Scholar 

  16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199

    Article  CAS  PubMed  Google Scholar 

  17. Yaguchi M, Miyazawa M, Otawa M, Katagiri T, Nishimaki J, Uchida Y, Iwase O, Gotoh A, Kawanishi Y, Toyama K . Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody Leukemia 1998 12: 1392–1397

    Article  CAS  PubMed  Google Scholar 

  18. Zhang C, Ao Z, Seth A, Schlossman SF . A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells J Immunol 1996 157: 3980–3987

    CAS  PubMed  Google Scholar 

  19. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K . Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form Blood 1995 85: 641–649

    CAS  PubMed  Google Scholar 

  20. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, Bolton WE . Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal, antibody APO2.7 Cytometry 1997 29: 306–312

    Article  CAS  PubMed  Google Scholar 

  21. Cossarizz A, Baccarani Contri M, Kalashinikova G, Franceschi C . A new method for cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation, 5, 5′, 6, 6′-tetrachloro-1, 1′, 3, 3′-tetraethylbenzimidazol carbocyanine iodide (JC-1) Biochem Biophys Res Commun 1993 197: 40–45

    Article  Google Scholar 

  22. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G . Mitochondrial control of nuclear apoptosis J Exp Med 1996 183: 1533–1544

    Article  CAS  PubMed  Google Scholar 

  23. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C . Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c Nature 1998 391: 496–499

    Article  CAS  PubMed  Google Scholar 

  24. Kokunai T, Izawa I, Tamaki N . Overexpression of p21CIP1 induces cell differentiation and growth inhibition in a human glioma cell line Int J Cancer 1998 5: 643–648

    Article  Google Scholar 

  25. Borriello A, Pietra VD, Criscuolo M, Oliva A, Tonini GP, Iolascon A, Zappia V, Ragione FD . p27KIP1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation Oncogene 2000 19: 51–60

    Article  CAS  PubMed  Google Scholar 

  26. Rots NY, Lavarone A, Bromleigh V, Freedman LP . Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression Blood 1999 93: 2721–2729

    CAS  PubMed  Google Scholar 

  27. Ohba M, Ishino K, Kashiwagi M, Kawabe S, Chida K, Huh NH, Kuroki T . Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C Mol Cell Biol 1998 18: 5199–5207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zhao X, Wakamatsu Y, Shibahara M, Nomura N, Geltinger C, Nakahara T, Murata T, Yokoyama KK . Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture Cancer Res 1999 59: 482–486

    CAS  PubMed  Google Scholar 

  29. Henry TR, Wallace KB . Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities Toxicol Appl Pharmacol 1995 134: 195–203

    Article  CAS  PubMed  Google Scholar 

  30. Fujita H, Tomiyama J, Tanaka T . Vitamin K2 combined with all-trans retinoic acid induced complete remission of relapsing acute promyelocytic leukaemia Br J Haematol 1998 103: 584–585

    Article  CAS  PubMed  Google Scholar 

  31. Green DR, Reed JC . Mitochondria and apoptosis (review) Science 1998 281: 1309–1312

    Article  CAS  PubMed  Google Scholar 

  32. Bossy-Wetzel E, Newmeyer DD, Green DR . Mitochondrial cytochrome c release in apoptosis occurs upstream on DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization EMBO J 1998 17: 37–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G . Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo J Exp Med 1995 181: 1661–1672

    Article  CAS  PubMed  Google Scholar 

  34. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ . The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release Mol Cell Biol 1998 18: 6353–6364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 1997 275: 1132–1136

    Article  CAS  PubMed  Google Scholar 

  36. Wang HG, Rapp UR, Reed JC . Bcl-2 targets the protein kinase Raf-1 to mitochondria Cell 1996 87: 629–638

    Article  CAS  PubMed  Google Scholar 

  37. Garland JM, Rudin C . Cytochrome c induces caspase-dependent apoptosis in intact hematopoietic cells and overrides apoptosis suppression mediated by bcl-2, growth factor signaling, MAP-kinase-kinase, and malignant change Blood 1998 92: 1235–1246

    CAS  PubMed  Google Scholar 

  38. Hoshi K, Nomura K, Sano Y, Koshihara Y . Nuclear vitamin K2 binding protein in human osteoblasts Biochem Pharmacol 1999 58: 1631–1638

    Article  CAS  PubMed  Google Scholar 

  39. Furukawa Y . Cell cycle control during hematopoietic cell differentiation Hum Cell 1997 10: 159–164

    CAS  PubMed  Google Scholar 

  40. Tamir A, Petrocelli T, Stetler K, Chu W, Howard J, Croix BS, Slingerland J, Ben-David Y . Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest Cell Growth Diff 2000 11: 269–277

    CAS  PubMed  Google Scholar 

  41. Baldassarre G, Barone MV, Belletti B, Sandomenico C, Bruni P, Spiezia S, Boccia A, Vento MT, Romano A, Pepe S, Fusco A, Viglietto G . Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation Oncogene 1999 18: 6241–6251

    Article  CAS  PubMed  Google Scholar 

  42. Kufe DW, Griffin JD, Spriggs DR . Cellular and clinical pharmacology of low-dose ara-C Semin Oncol 1985 12: 200–207

    CAS  PubMed  Google Scholar 

  43. Katagiri T, Miyazawa K, Nishimaki J, Yaguchi M, Kawanishi Y, Ohyashiki K . Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro Leuk Lymphoma 2000 39: 173–184

    Article  CAS  PubMed  Google Scholar 

  44. Wolf D, Rotter V . Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells Proc Natl Acad Sci USA 1985 82: 790–794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y . Waf1/cip1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 1994 54: 11629–1174

    Google Scholar 

  46. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S . Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation EMBO J 1999 18: 1223–1234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Orimo H, Shiraki M, Tomita A, Morri H, Fujita T, Ohata M . Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: a double-blind placebo-controlled study J Bone Miner Metab 1998 16: 106–112

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study is supported by a Grant-in-Aid for Science Research (C) from the Ministry of Education, Science, Sports and Culture of Japan to KM (#11671017) and MY (#670968). We thank Ayako Hirota for her excellent technical assistance. We also thank Eisai Chemical Co. (Tokyo, Japan) for providing menaquinone-4 and phytonadione.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyazawa, K., Yaguchi, M., Funato, K. et al. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia 15, 1111–1117 (2001). https://doi.org/10.1038/sj.leu.2402155

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402155

Keywords

This article is cited by

Search

Quick links